Navigation Links
Small Animal Imaging (In Vivo) Market - By systems and reagents [Micro-PET, Optical Imaging, Micro-MRI, Micro-SPECT, Micro-Ultrasound, Micro-CT & Multimodality/Hybrid Imaging Modalities] - Competitive Analysis & Global Forecasts to 2017
Date:1/29/2013

cation of Functional Imaging 41

3.3.1.4 Increasing Number of Pharma Companies and Research Institutions 42

3.3.2 RESTRAINTS 42

3.3.2.1 High Device Cost 42

3.3.2.2 Technological Limitations 43

3.3.2.3 High Cost and Data Requirements for Bringing New Technology 43

3.3.3 OPPORTUNITIES 44

3.3.3.1 Next Unique Combinations in MRI 44

3.3.3.2 High Resolution & Sensitivity of Imaging Devices with Usage in Multiple Applications 44

3.3.3.3 Emerging Markets 45

3.3.4 CHALLENGES 45

3.3.4.1 Sustainability of Players in Highly Competitive Market 45

3.3.4.2 Availability of Radiopharmaceuticals 46

3.4 MARKET SHARE ANALYSIS 47

3.4.1 BY TECHNOLOGY 47

3.4.2 BY MARKET PLAYERS 47

3.4.3 BY GEOGRAPHY 50

 

4 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) SYSTEMS MARKET, BY TECHNOLOGY 51

4.1 INTRODUCTION 52

4.2 STANDALONE TECHNOLOGY FOR SMALL ANIMAL IMAGING (IN VIVO) 54

4.2.1 NUCLEAR IMAGING 57

4.2.1.1 Micro-SPECT 59

4.2.1.2 Micro-PET 60

4.2.2 OPTICAL IMAGING 62

4.2.2.1 Fluorescence 65

4.2.2.2 Bioluminescence 66

4.2.2.3 Near Infrared Fluorescence 67

4.2.3 MICRO-MRI 69

4.2.4 MICRO-CT 71

4.2.5 MICRO-ULTRASOUND 73

4.3 MULTIMODAL IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO) 75

4.3.1 MULTIMODAL NUCLEAR IMAGING DEVICES 76

4.3.1.1 SPECT + CT 77

4.3.1.2 SPECT + MR 78

4.3.1.3 PET + CT 79

4.3.1.4 PET + MR 80

4.3.1.5 SPECT + PET + CT 81

4.3.2 MULTIMODAL OPTICAL IMAGING DEVICES 82

4.3.2.1 Optical+ X-ray + Radioisotopic 82

 

5 GLOBAL SMALL ANIMAL IMAGING (IN VIVO) MARKET, BY REAGENTS 83

5.1 INTRODUCTION 84

5.2 NUCLEAR IMAGING FOR SMALL ANIMAL IMAGING (IN VIVO) 86

5.2.1 PET TRACERS 88

5.2.1.1 Fluorine-18 based 92

5.2.1.2 Carbon-11 based 93

5.2.1.3 Copper-64 based 94

5.2.1.4
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival
3. U.S. Government Supports Phase 3 Study of Bavarian Nordics Smallpox Vaccine
4. Medical Marijuana Inc. (MJNA) Corporate Update on Industry Company Services and Future Development. First Audio-Webcast Interview With SmallCapVoice.com in Quarterly Series
5. A New Audio Interview With Ronald Adams President Of Medical Alarm Concepts Holding, Inc., Is Now At SmallCapVoice.com
6. Viztek Debuts Upgraded Opal-Ortho Appliance; Offers Small "One Box" Footprint for Private Practices Combining CR/DR and PACS
7. Protected Classes Prescription Drug Mandates Would Hike Small Business Costs, Drug Company Profits
8. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
9. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
10. CanCHEW Bio-Technologies, a Medical Marijuana Inc. Product, Dr. George Anastassov Appeared on Small Cap Voice Internet Radio Program To Discuss The CanCHEW Advantage
11. Varian Medical Systems to Support an NCI-Sponsored Phase III Study Comparing Radiosurgery with Surgery for the Treatment of Early-Stage High-Risk, Operable Non-Small Cell Lung Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2014)... -- Amgen (NASDAQ: AMGN ) today announced ... results include: , Total revenues increased 11 percent ... driven by strong performance across the portfolio, particularly Enbrel ... (denosumab) and XGEVA ® (denosumab). , ... higher revenues and a significant increase in the profitability ...
(Date:7/29/2014)... , July 29, 2014  Alexza Pharmaceuticals, Inc. (Nasdaq: ... participating in two healthcare conferences during the third quarter, ... Morgan Stanley Global Healthcare 2014 Conference.  Alexza,s corporate presentation ... The details on each event are below: ... 11, 2014 in Boston , MA.  ...
(Date:7/29/2014)... Md. , July 29, 2014  Synthetic Biologics, ... biologic and drug candidates targeting specific pathogens that cause ... of the unusual market activity in the Company,s stock, ... in accordance with its usual practice. The Company stated ... market activity. About Synthetic Biologics, Inc. ...
Breaking Medicine Technology:Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 2Alexza Pharmaceuticals Announces Participation in Upcoming Investor Conferences 3Synthetic Biologics, Inc. States that Its Policy is Not to Comment on Unusual Market Activity 2
... is little evidence to support the use of atypical ... approved purposes, even though many clinicians continue to commonly ... to a new report from the U.S. Department of ... and Quality (AHRQ). An article based on information in ...
... The Houston Business Journal recently announced that eCardio Diagnostics ... Fast 100, which included a distinguished list of 100 of ... eCardio was ranked No. 17 with a two-year growth ... to receive this prestigious award. "There were so ...
Cached Medicine Technology:"Off-Label" Use of Antipsychotic Drugs for Some Conditions Not Supported By Evidence 2eCardio Among Honorees of the Houston Business Journal's Fast 100 List for Second Consecutive Year 2
(Date:7/30/2014)... Connecticut (PRWEB) July 30, 2014 Pain ... new magnetic sports bracelet for pain relief and improved ... strength carbonized titanium embedded in a silicone core that ... also has Germanium and is embedded with scalar energy ... bracelet. , “Pain Free Living has 12 years experience ...
(Date:7/29/2014)... July 29, 2014 Paul Mata, CEO of ... More Money in 30 Days” E-book. The e-book includes a ... to make extra cash. Examples include downloading and utilizing specific ... websites that help people monetize the assets they didn't know ... items they can find in their garage. , After ...
(Date:7/29/2014)... 1Heart Caregiver Services’ advocacy on ... on Brain Fitness Education brings great acceptance from ... Program Director Tee Barr delivered an exceptional Brain ... and the Assisted Living section of Aegis Ventura ... Christy Rozsa and Aegis Life Neighborhood Director Christine ...
(Date:7/29/2014)... 29, 2014 Daily Gossip indicates that ... all other disturbing symptoms that hemorrhoids commonly causes. The ... and natural medicine expert. , The author of ... the elimination of symptoms such as itching, burning, pain ... more about the H Miracle by visiting the official ...
(Date:7/29/2014)... 2014 The One Minute Herpes Cure review ... an herbal medicine specialist. Alison Freeman wanted to show her ... , People interested in finding out more about this method ... it, as it is currently available in online format. , ... remedies and herbal medicine tips that can help them achieve ...
Breaking Medicine News(10 mins):Health News:Superior Magnetics Released New Magnetic Sports Bracelet for Pain 2Health News:Create Indestructible Wealth Launches Innovative E-Book: “Realistic Ways to Make More Money in 30 Days” 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 2Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 3Health News:1Heart Caregiver Services Conducts Brain Fitness Education and Brings Tee Barr to Aegis Ventura 4Health News:H Miracle Review Exposes Natural Method to Cure Hemorrhoids 2Health News:One Minute to Herpes Cure Review Reveals Simplest Herpes Treatment 2
... say, Montelukast, a leukotriene-receptor antagonist (leukotrienes mediate inflammation // ... reactions), decreased incidents of asthma in young children by ... ,Researchers conducted a one-year study involving 549 children ... 278 of the children received low-dose montelukast once a ...
... considered till now that after delivery depressions, that had plagued new ... trauma of the delivery. As a result of this belief, many ... depression. A new study that comes in the recent issue of ... ,According to Deirdre Murphy of Dundee University, who had led ...
... treat patients with acute traumatic brain injury, may lead to ... & Tropical Medicine. ,British researchers had studied the ... brain injury. The study was conducted to see the effect ... results showed that there seems to be an increase in ...
... their mothers to see if there was a link between ... life and children's antisocial behavior by age 7 , researchers ... problems with conduct and more antisocial behavior . ,Results ... birth and the likeliness of antisocial behavior in children by ...
... to a recent study researchers say those in the ... // an increased risk of suicidal behavior . ... and other clinical conditions were studied. Patients taking SSRIs ... taking placebo. Researchers say they found no difference ...
... Quetiapine, a drug used to treat agitation in patients ... say researchers based on findings of a recent study ... patients were observed . Twenty-six of the patients received ... rivastigmine (a cholinesterase inhibitor also known as Exelon), and ...
Cached Medicine News:
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: